Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The Problem of Origins and Origins of the Problem: Influence of Language on Studies Concerning the Anomeric Effect.

Filloux CM.

Angew Chem Int Ed Engl. 2015 Jul 27;54(31):8880-94. doi: 10.1002/anie.201411185. Epub 2015 Jun 26.

PMID:
26119827
2.

Rh(I)-bisphosphine-catalyzed asymmetric, intermolecular hydroheteroarylation of α-substituted acrylate derivatives.

Filloux CM, Rovis T.

J Am Chem Soc. 2015 Jan 14;137(1):508-17. doi: 10.1021/ja511445x. Epub 2014 Dec 29.

3.

Integrative view of α2,3-sialyltransferases (ST3Gal) molecular and functional evolution in deuterostomes: significance of lineage-specific losses.

Petit D, Teppa E, Mir AM, Vicogne D, Thisse C, Thisse B, Filloux C, Harduin-Lepers A.

Mol Biol Evol. 2015 Apr;32(4):906-27. doi: 10.1093/molbev/msu395. Epub 2014 Dec 21.

4.

An integrative method to normalize RNA-Seq data.

Filloux C, Cédric M, Romain P, Lionel F, Christophe K, Dominique R, Abderrahman M, Daniel P.

BMC Bioinformatics. 2014 Jun 14;15:188. doi: 10.1186/1471-2105-15-188.

5.

Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice.

Mothe-Satney I, Filloux C, Amghar H, Pons C, Bourlier V, Galitzky J, Grimaldi PA, Féral CC, Bouloumié A, Van Obberghen E, Neels JG.

Diabetes. 2012 Sep;61(9):2311-9. doi: 10.2337/db11-1455. Epub 2012 Jun 11.

6.

Multicatalytic, asymmetric Michael/Stetter reaction of salicylaldehydes and activated alkynes.

Filloux CM, Lathrop SP, Rovis T.

Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20666-71. doi: 10.1073/pnas.1002830107. Epub 2010 Jul 16.

7.

The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion.

Lebrun P, Cognard E, Gontard P, Bellon-Paul R, Filloux C, Berthault MF, Magnan C, Ruberte J, Luppo M, Pujol A, Pachera N, Herchuelz A, Bosch F, Van Obberghen E.

Diabetologia. 2010 Sep;53(9):1935-46. doi: 10.1007/s00125-010-1786-9. Epub 2010 May 25.

PMID:
20499047
8.

Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice.

Lebrun P, Cognard E, Bellon-Paul R, Gontard P, Filloux C, Jehl-Pietri C, Grimaldi P, Samson M, Pénicaud L, Ruberte J, Ferre T, Pujol A, Bosch F, Van Obberghen E.

Diabetologia. 2009 Oct;52(10):2201-12. doi: 10.1007/s00125-009-1474-9. Epub 2009 Aug 12.

PMID:
19672574
9.

The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells.

Emanuelli B, Glondu M, Filloux C, Peraldi P, Van Obberghen E.

Diabetes. 2004 Dec;53 Suppl 3:S97-S103.

10.

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.

Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, Van Obberghen E.

J Biol Chem. 2001 Dec 21;276(51):47944-9. Epub 2001 Oct 16.

11.

Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase.

Peraldi P, Filloux C, Emanuelli B, Hilton DJ, Van Obberghen E.

J Biol Chem. 2001 Jul 6;276(27):24614-20. Epub 2001 Apr 26.

12.

SOCS-3 is an insulin-induced negative regulator of insulin signaling.

Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E.

J Biol Chem. 2000 May 26;275(21):15985-91.

13.

Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase.

Filippa N, Sable CL, Filloux C, Hemmings B, Van Obberghen E.

Mol Cell Biol. 1999 Jul;19(7):4989-5000.

14.

Involvement of the pleckstrin homology domain in the insulin-stimulated activation of protein kinase B.

Sable CL, Filippa N, Filloux C, Hemmings BA, Van Obberghen E.

J Biol Chem. 1998 Nov 6;273(45):29600-6.

15.

Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.

Némoz-Gaillard E, Cordier-Bussat M, Filloux C, Cuber JC, Van Obberghen E, Chayvialle JA, Abello J.

Biochem J. 1998 Apr 1;331 ( Pt 1):129-35.

16.

Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.

Mothe I, Delahaye L, Filloux C, Pons S, White MF, Van Obberghen E.

Mol Endocrinol. 1997 Dec;11(13):1911-23.

PMID:
9415396
17.

Identification of Stat 5B as a substrate of the insulin receptor.

Sawka-Verhelle D, Filloux C, Tartare-Deckert S, Mothe I, Van Obberghen E.

Eur J Biochem. 1997 Dec 1;250(2):411-7.

18.

Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor.

Sawka-Verhelle D, Baron V, Mothe I, Filloux C, White MF, Van Obberghen E.

J Biol Chem. 1997 Jun 27;272(26):16414-20.

19.

The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor.

Calleja V, Ruiz Enríquez P, Filloux C, Peraldi P, Baron V, Van Obberghen E.

Endocrinology. 1997 Mar;138(3):1111-20.

PMID:
9048617
20.

Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1.

Frödin M, Sekine N, Roche E, Filloux C, Prentki M, Wollheim CB, Van Obberghen E.

J Biol Chem. 1995 Apr 7;270(14):7882-9.

21.

Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP.

Peraldi P, Frödin M, Barnier JV, Calleja V, Scimeca JC, Filloux C, Calothy G, Van Obberghen E.

FEBS Lett. 1995 Jan 9;357(3):290-6.

22.

Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinase.

Peraldi P, Zhao Z, Filloux C, Fischer EH, Van Obberghen E.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):5002-6.

25.
26.

Insulin and orthovanadate stimulate multiple phosphotyrosine-containing serine kinases.

Scimeca JC, Ballotti R, Filloux C, Van Obberghen E.

Mol Cell Biochem. 1992 Feb 12;109(2):139-47.

PMID:
1378174
27.

Activation of insulin-epidermal growth factor (EGF) receptor chimerae regulates EGF receptor binding affinity.

Tartare S, Ballotti R, Lammers R, Filloux C, Chauvel A, Schlessinger J, Ullrich A, Van Obberghen E.

J Cell Biol. 1992 Feb;116(3):627-33.

28.

Phenylarsine oxide stimulates a cytosolic tyrosine kinase activity and glucose transport in mouse fibroblasts.

Ballotti R, Tartare S, Chauvel A, Scimeca JC, Alengrin F, Filloux C, Van Obberghen E.

Exp Cell Res. 1991 Dec;197(2):300-6.

PMID:
1659989
29.

Tyrosine and threonine phosphorylation of an immunoaffinity-purified 44-kDa MAP kinase.

Scimeca JC, Ballotti R, Nguyen TT, Filloux C, Van Obberghen E.

Biochemistry. 1991 Sep 24;30(38):9313-9.

PMID:
1716457
30.

Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone.

Debant A, Clauser E, Ponzio G, Filloux C, Auzan C, Contreres JO, Rossi B.

Proc Natl Acad Sci U S A. 1988 Nov;85(21):8032-6.

Supplemental Content

Loading ...
Support Center